Finally, we think that our study (limited to missense variants in two functional domains of the tumor-suppressor gene BRCA1) illustrates some general principles and recommendations that might be relevant in evaluating PP3/BP4 computational evidence in other proteins. The gene discussed is BRCA1; the disease is neoplasm.